Clinical Trials : Perlman Syndrome

Completed

Study Name: A Phase II Study of Topotecan in Children With Recurrent Wilms Tumor
Condition: Wilms Tumor
Date: 2005-09-12
Interventions: Drug: Topotecan, Filgrastim (G-CSF), Pegfilgrastim See detailed description section for additional detai

Recruiting

Study Name: Collaborative Wilms Tumour Africa Project
Condition: Wilms Tumour
Date: 2013-11-12

Withdrawn

Study Name: National Wilm's Tumor Study Late Effects
Condition: Wilm's Tumor
Date: 2005-09-27
Interventions: Other: none, screening only Screening protocol with no intervention

Active, not recruiting

Study Name: Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
Condition:

Stage III Wilms Tumor With Loss of Heterozygosity (LOH) for 1p and 16q
Drug: doxorubicin hydrochloride

Completed

Study Name: Biomarkers in Samples From Younger Patients With Wilms Tumor
Condition: Wilms Tumor and Other Childhood Kidney Tumors
Date: 2011-12-15
Interventions: Other: laboratory biomarker analysis Correlative studies

Completed

Study Name: Studying Biomarkers in Urine Samples From Younger Patients With Wilms Tumor
Condition:

Recurrent Wilms Tumor and Other Childhood Kidney Tumors
Stage I
Date: 2012-06-06
Interventions: Other: laboratory biomarker analysis Correlative studies

Completed

Study Name: A Phase II Trial of All-Trans-Retinoic Acid in Combination With Interferon-Alpha 2a in Children With Recurrent Neuroblastoma or Wilms' Tumor
Condition:

Nephroblastoma
Neuroblastoma

Date: 1999-11-03
Interventions: Drug: IFN-alpha with retinoic acid

Completed

Study Name: Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Condition:

Stage I Wilms Tumor
Stage II
Wilms Tumor<
Date: 2006-07-13
Interventions:
- Procedure: therapeutic conventional surgery

Completed

Study Name: WT1 Peptid Vaccination in Carcinomas
Condition: WT1 Expressing Carcinoma
Date: 2005-09-08
Interventions: Biological: WT1 126-134 peptide

Recruiting

Study Name: Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors
Condition:

Ewing Sarcoma
Rhabdomyosarcoma
Wilms
Date: 2015-10-19
Interventions: Radiation: Stereotactic Body Radiotherapy (SBRT)

Search for Clinical Trial Results

Perlman Syndrome - 21 Studies Found

Status	Study
Completed	Study Name: A Phase II Study of Topotecan in Children With Recurrent Wilms Tumor Condition: Wilms Tumor Date: 2005-09-12 Interventions: Drug: Topotecan, Filgrastim (G-CSF), Pegfilgrastim See detailed description section for additional detai
Recruiting	Study Name: Collaborative Wilms Tumour Africa Project Condition: Wilms Tumour Date: 2013-11-12
Withdrawn	Study Name: National Wilm's Tumor Study Late Effects Condition: Wilm's Tumor Date: 2005-09-27 Interventions: Other: none, screening only Screening protocol with no intervention
Active, not recruiting	Study Name: Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor Condition: Stage III Wilms Tumor With Loss of Heterozygosity (LOH) for 1p and 16q Drug: doxorubicin hydrochloride
Completed	Study Name: Biomarkers in Samples From Younger Patients With Wilms Tumor Condition: Wilms Tumor and Other Childhood Kidney Tumors Date: 2011-12-15 Interventions: Other: laboratory biomarker analysis Correlative studies
Completed	Study Name: Studying Biomarkers in Urine Samples From Younger Patients With Wilms Tumor Condition: Recurrent Wilms Tumor and Other Childhood Kidney Tumors Stage I Date: 2012-06-06 Interventions: Other: laboratory biomarker analysis Correlative studies
Completed	Study Name: A Phase II Trial of All-Trans-Retinoic Acid in Combination With Interferon-Alpha 2a in Children With Recurrent Neuroblastoma or Wilms' Tumor Condition: Nephroblastoma Neuroblastoma Date: 1999-11-03 Interventions: Drug: IFN-alpha with retinoic acid
Completed	Study Name: Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor Condition: Stage I Wilms Tumor Stage II Wilms Tumor< Date: 2006-07-13 Interventions: Procedure: therapeutic conventional surgery
Completed	Study Name: WT1 Peptid Vaccination in Carcinomas Condition: WT1 Expressing Carcinoma Date: 2005-09-08 Interventions: Biological: WT1 126-134 peptide
Recruiting	Study Name: Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors Condition: Ewing Sarcoma Rhabdomyosarcoma Wilms Date: 2015-10-19 Interventions: Radiation: Stereotactic Body Radiotherapy (SBRT)